News

• 8/23/2023

Fifty Years VC accepted our CEO, Uroš Kuzmanović, into the Fifty 50 cohort 3! Fifty 50 is comprised of bio and climate-focused PhDs and postdocs who want to bring innovation from their lab to the world to create a massive positive impact with their work. Fifty 50 helps world-class scientists become world-class entrepreneurs. They connect entrepreneurial scientists with the community and knowledge they need to start generational companies.

• 7/31/2023

BioSens8 submitted an NSF SBIR Phase II application following on their STTR Phase I 'Novel progesterone biosensor for monitoring fertility health'. We're looking forward to continuing exciting work with the NSF!

• 7/17/2023

BioSens8 was successfully accepted into the NVIDIA Inception Program!! NVIDIA Inception will drive BioSens8’s business forward through go-to-market support, training, and technology assistance to lay the foundation for implementing AI/ML to their vast and novel data sets. Thank you NVIDIA!

• 6/28/2023

BioSens8 participated in the New England Venture Capital Association Unpitch HEALTH event where we got to talk to the AWS team, JJDC, and Third Culture Capital! Thanks for having us NEVCA! 

• 6/14/2023

Come talk to BioSens8 at our booth for the Cohort 9 TiE ScaleUp Investor Showcase event at the Microsoft NERD Center in Kendall! We'll be there in person to answer all questions about our technology and give outlook on our goals for the next 12 months. Investors and strategic partners are encouraged to join!

• 5/18/2023

Our CEO, Uroš Kuzmanović, was awarded the Outstanding Dissertation Award for his thesis 'Mining Microbes to Engineer Novel Biosensors' during the Boston University College of Engineering Graduate Convocation!! Congratulations Uroš!

• 5/11-13/2023

BioSens8 was awarded the Edward H. Molter Memorial Prize for 3rd place in the Wildcard Round at the 2023 Rice Business Plan Competition! Thanks to all the judges that provided valuable feedback during the competition.

• 4/27-28/2023

BioSens8 will be at TiECON East 'The Rise of the Intentional Entrepreneur"! Join us among the other impressive startups, investors, and entrepreneurs! 

• 4/3-7/2023

BioSens8 is participating in a unique virtual matchmaking event for health tech startups and investors hosted by SOSV. Sign up and meet us there!

• 3/23/2023

BioSens8 was selected as a semi-finalist for the 2048 Biotech Competition by 2048 Ventures out of more than 120 teams to compete for a $200K uncapped SAFE!

• 3/22/2023

BioSens8 is one of 42 finalists in the 2023 Rice Business Plan Competition among others from 6 countries and 37 universities! Come watch us compete in Houston, TX from 5/11-13!

• 3/8-10/2023

BioSens8 was at the Hello Tomorrow Global Summit in Paris, France participating as a DeepTech Pioneer! After speed dating with investor during Investor Day on 3/8 there were fascinating talks given by field experts the following two days.

• 2/15-16/2023

BioSens8 participated in the Reproductive Health Innovation Summit (RHIS) in Boston, MA talking to other women's health companies, physicians, and startup founders to learn more about the field and how we could bring value. 

• 2/3/2023

BioSens8 was recently accepted into the TiE ScaleUp Accelerator Cohort 9! We're excited to work with experienced mentors in the TiE Boston community to move our company forward with this program.

• 1/25/2023

Our CEO, Uroš Kuzmanović, represented BioSens8 at the ECUSA Forward Local Entrepreneurship Showcase at Harvard! Check out the event details here. 

• 1/23/2023

Maria Kloiber, a recent Boston University Mechanical Engineering MS graduate, joined the BioSens8 team! Welcome Maria!!

2023

• 12/6/2022

Our CEO, Uroš Kuzmanović, successfully defended his PhD in Biomedical Engineering from Boston University! He's excited to take BioSens8 to new levels in 2023.

• 11/24/2022

BioSens8 was named a Deep Tech Pioneer by Hello Tomorrow! From thousands of applications their experts saw real potential in our technology and solution. Come meet us in Paris from 3/8-10!

• 11/8/2022

Our CEO, Uroš Kuzmanović, was awarded 2022 Rising Entrepreneur of the Year Award by TiE Boston!! The event was celebrated at an annual TiE Boston Gala where the accomplishments of other awardees was celebrated. Check out more about the award, Uroš's interview, and more here. 

• 10/6/2022 

BioSens8 participated in the Engineering and Biotech Career Fair at Boston University! We had the pleasure to meet talented engineers which were excited to intern for BioSens8. We were left with over 100 resumes to look over!

• 9/6/2022

Our CEO, Uroš Kuzmanović, was recently spotlighted on the BU OTD newsletter for his tremendous work in getting the company to its current stage. Congratulations Uroš!!

• 9/1/2022

The BioSens8 team officially moved into the wonderful Nest.Bio Labs space in Cambridge, MA! They're excited to continue growing the team and commercialize their product alongside all the other impressive companies in that space.

• 7/28/2022

Our CEO, Uroš Kuzmanović, represented BioSens8 in the previous HealthTech Build panel discussing changing consumer trends, political climate, and standard of care in women's healthcare! Check out the recording if you missed it!

• 7/20/2022

BioSens8 was honored to participate in the third UMassM2D2 IMPACT Accelerator and partake in the Showcase Day at the UMass Lowell Innovation Hub! It's been an pleasure advancing and improving women's health alongside 9 other startups and our main sponsor Hologic, Inc.. BioSens8 won an Impact Program Award from RedCrow and a Judges Award from Upteaming! 

• 6/27/2022

BioSens8 was selected as a semi-finalist in the 2022 Pepperdine Most Fundable Companies competition! We are part of a select group of approximately 100 semi-finalists chosen from over 4,000 participants nationwide. 

• 6/10/2022

Our CEO, Uroš Kuzmanović, was nominated for the Tech Startup Hustle Project,  a selective study investigating founder cognition supported by Ball State University and Indiana University! Congratulations! 

• 5/18/2022

BioSens8 was awarded the Hatch@Nest.Bio award at the Nucleate New England Final Pitch Showcase!! This award provides us 6 months of lab space in the wonderful Nest.Bio incubator space in Cambridge, MA. We're excited to join the cohort there!

• 5/15/2022

BioSens8 represented TiE Boston at the TiE University Global Global Pitch Competition and won 1st place!! The TiE University Global pitch competition brought together 30 winning teams virtually from TIE Chapters in eight countries across three continents. Local TiE Charters had participation from 1,455 startup teams with 3,676 college students, representing 24 countries! Check out our press release here!

• 4/25/2022

BioSens8 was accepted into the M2D2 IMPACT Accelerator Program sponsored by Hologic, Inc. with a particular focus on innovating in women's healthcare! We're joined by 9 other startups on this 12 week program. Check out the previous cohort results and the current teams here. 

• 4/6/2022

BioSens8 won the 1st place prize at the M2D2 $200K Challenge!! What a thrilling night at the UMass Club downtown shared with other innovators, entrepreneurs, and investors. Thank you to Hologic, Inc., Massachusetts Life Sciences Center, and MPR Associates, Inc. for sponsoring our efforts! Check out event recap here. 

• 3/30/2022

BioSens8 won 1st place in the TiE Boston - University Regional Pitch Competition! We were among 90 teams from across the world who have made it to the global cohort  after competing with 3660 student entrepreneurs from 1451 teams spanning 24 countries. We'll be participating in the global pitch competition as a result!

• 3/15/2022

BioSens8 progressed through the semi-final round and will participate in the 2022 MIT Sloan Healthcare Innovations Prize Finals! We're excited to pitch on 3/31/22!

• 3/9/2022

BioSens8 is once again a M2D2 $200K Challenge Finalist! Come watch us pitch in person on 3/22/22!

• 2/24/2022

BioSens8 advanced as a semi-finalists for the TiE Boston - University Regional Pitch Competition! We'll be pitching on 3/30/2022 for a chance to advance to the finals!

2022

• 12/24/2021

BioSens8 was accepted into the Nucleate accelerator 2022 cohort! We'll be working through Spring engaging with clinical and business mentors to grow our company. 

• 11/9/2021

BioSens8 is participating as a host company in Brown University's PRIME graduate program in order to discover potential markets we can enter with our IP. 

• 10/12/2021

BioSens8 engaged in NSF's Beat the Odds Bootcamp in order to complete even further customer discovery in the human fertility market segment. 

• 9/20/2021

BioSens8 is participating as a host company in the Boston University Questrom business school class, Bench to Bedside, to discover potential markets our platform technology can be applied toward and then follow with customer discovery! 

• 9/14/2021

BioSens8 is participating as a host company in the MIT Sloan business school class,  E-Lab, to diver deeper into unmet needs and identify the value propositions of our progesterone biosensor in the FemTech space!

• 7/20/2021

NSF has awarded our STTR Phase I proposal for developing a novel progesterone biosensor for monitoring fertility health! We're delighted to have the support of NSF, the funds will be used for achieving technical milestones required for commercialization. 

• 6/28/2021

BioSens8 was selected from more than 3000 global applicants to join the MassChallenge 2021 cohort! We're excited to partake alongside 228 other startups!

• 5/3/2021

Boston University has awarded Dr. James Galagan with the Ignition Award! The funds will be used for R&D work toward bringing a novel animal healthcare biosensor to market.

• 4/7/2021

BioSens8 was awarded the 2nd place prize at the M2D2 $200K Challenge! We're thrilled to be supported by M2D2 with a cash award! Check out our award winning pitch. 

• 4/7/2021

BioSens8 pitched in front of a panel of Med Tech judges including industry leaders, investors, and practitioners for the BU Ignition Award.

• 3/8/2021

BioSens8 was selected as a M2D2 $200K Finalist! We were one of 15 startups (out of more than 170 worldwide entrants) in the running for $200,000 in in-kind services and research support from sponsors that include UMass Lowell, Amgen, Boston Scientific, Johnson & Johnson Innovation, Massachusetts Life Sciences Center, Mintz, and others. 

The virtual M2D2 $200K Challenge Finalist Pitch-off being hosted through Zoom on Wednesday, March 24th. Register for free and watch us pitch here!

• 3/4/2021

BioSens8 successfully submitted a NSF STTR Phase I application.

• 2/11/2021

BioSens8 was selected as a Boston University Ignition Award finalist! Our full proposal was well received by the Ignition Review Committee, made up of outside representatives (investors, industry) and BU academics. As a finalist, BioSens8 will present for the Ignition Award on 4/7/2021.

2021

• 12/16/2020

BioSens8 officially incorporated.

• 11/23/2020

BioSens8 was selected to submit a full proposal for the Boston University Ignition Award! The Ignition Award program is designed to help Boston University researchers bring their projects with commercial potential to the next level. 

• 10/15/2020

BioSens8 was accepted to partake in the NSF NE I-Corps Spark Program to perform customer discovery!

2020